Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

  1. 16,304 Posts.
    lightbulb Created with Sketch. 6222
    It's been 8 months in November since we were told:

    "the U.S. FDA supports an accelerated approval pathway for rexlemestrocel-L, Mesoblast’s allogeneic mesenchymal precursor cell (MPC) product, in patients with end-stage ischemic heart failure with reduced ejection fraction (HFrEF) and a left ventricular assist device (LVAD)"

    ..... and still no meeting (that we know of) ?  Get on with it ... lol



    upload_2024-10-31_10-8-22.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.49
Change
0.000(0.00%)
Mkt cap ! $3.187B
Open High Low Value Volume
$2.53 $2.55 $2.48 $9.615M 3.829M

Buyers (Bids)

No. Vol. Price($)
1 200 $2.49
 

Sellers (Offers)

Price($) Vol. No.
$2.50 4078 2
View Market Depth
Last trade - 16.10pm 29/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.